File Image: The logo of the pharmaceutical company AstraZeneca is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, USA on April 8, 2019. . / Brendan McDermid (Brendan McDermid /)

MEXICO CITY, Aug 13 (.) – The manufacturing of the COVID-19 vaccine agreed by the governments of Mexico and Argentina with the pharmaceutical company AstraZeneca would begin in the first quarter of 2021 for immediate distribution, originally planned for Latin America. a company executive said Thursday.

The general director of the company in the North American country, Sylvia Varela, said in a press conference with the Mexican president, Andrés Manuel López Obrador, that the trials in phase III of the product would end between the end of November or December, and then be able to be authorized.

AstraZeneca signed an agreement with the Mexican billionaire Carlos Slim’s foundation for the production of the vaccine that it plans to deliver from the first half of 2021, based on the results of Phase III studies and regulatory approvals.

(Reporting by Daina Beth Solomon and Raúl Cortés Fernández; Edited by Ana Isabel Martínez)